Evidence map›Paper›PMID 38135724›Full record

ArticlePediatric research2024

COHESION: a core outcome set for the treatment of neonatal encephalopathy.

Fiona A Quirke, Shabina Ariff, Malcolm R Battin, Caitlin Bernard, Linda Biesty, Frank H Bloomfield, Mandy Daly, Elaine Finucane, Patricia Healy, David M Haas and 13 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Pediatric research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 14 institutions in 7 countries.

Fiona A QuirkeHealth Research Board Neonatal Encephalopathy PhD Training Network (NEPTuNE), Dublin, Ireland. 22306056@studentmail.ul.ie.ORCID 0000-0001-9155-5543
Shabina AriffDepartment of Paediatrics & Child Health, Aga Khan University, Karachi, Pakistan.
Malcolm R BattinDepartment of Newborn Services, Auckland District Health Board, Auckland, New Zealand.
Caitlin BernardDepartment of Obstetrics and Gynecology, Indiana University, Indianapolis, IN, US.
Linda BiestyEvidence Synthesis Ireland, University of Galway, Galway, Ireland.
Frank H BloomfieldLiggins Institute, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Mandy DalyAdvocacy and Policymaking, Irish Neonatal Health Alliance, Wicklow, Ireland.
Elaine FinucaneEvidence Synthesis Ireland, University of Galway, Galway, Ireland.
Patricia HealyEvidence Synthesis Ireland, University of Galway, Galway, Ireland.
David M HaasDepartment of Obstetrics and Gynecology, Indiana University, Indianapolis, IN, US.
Jamie J KirkhamCentre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Vincent KibetMoi University, Cheptiret, Kenya.
Sarah KoskeiMoi University, Cheptiret, Kenya.
Shireen MeherBirmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Eleanor J MolloyHealth Research Board Neonatal Encephalopathy PhD Training Network (NEPTuNE), Dublin, Ireland.
Maira NiazDepartment of Paediatrics & Child Health, Aga Khan University, Karachi, Pakistan.
Elaine Ní BhraonáinFamily Support Liaison, Irish Neonatal Health Alliance, Wicklow, Ireland.
Christabell Omukagah OkarononAMPATH, Eldoret, Kenya.
Matthew J ParkesCentre for Statistics in Medicine; Nuffield Dept of Orthopaedics Rheumatology and Musculoskeletal Science, University of Oxford, Oxfordshire, UK.
Farhana TabassumCentre of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan.
Karen WalkerDepartment of Newborn Care, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
James W H WebbeAcademic Neonatal Medicine, Imperial College London, London, UK.
Declan DevaneHealth Research Board - Trials Methodology Research Network (HRB-TMRN), University of Galway, Galway, Ireland.
Ollscoil na Gaillimhe – University of Galway · IEAga Khan University · PKIndiana University – Purdue University Indianapolis · USMoi University · KEAMPATH · KEAuckland District Health Board · NZBirmingham Women’s and Children’s NHS Foundation Trust · GBImperial College London · GBManchester Academic Health Science Centre · GBNuffield Orthopaedic Centre · GBThe University of Sydney · AUTrinity College Dublin · IEUniversity of Auckland · NZUniversity of Limerick · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeterogeneity in outcomes reported in trials of interventions for the treatment of neonatal encephalopathy (NE) makes evaluating the effectiveness of treatments difficult. Developing a core outcome set for NE treatment would enable researchers to measure and report the same outcomes in future trials. This would minimise waste, ensure relevant outcomes are measured and enable evidence synthesis. Therefore, we aimed to develop a core outcome set for treating NE.

methodsOutcomes identified from a systematic review of the literature and interviews with parents were prioritised by stakeholders (n = 99 parents/caregivers, n = 101 healthcare providers, and n = 22 researchers/ academics) in online Delphi surveys. Agreement on the outcomes was achieved at online consensus meetings attended by n = 10 parents, n = 18 healthcare providers, and n = 13 researchers/ academics.

resultsSeven outcomes were included in the final core outcome set: survival; brain injury on imaging; neurological status at discharge; cerebral palsy; general cognitive ability; quality of life of the child, and adverse events related to treatment.

conclusionWe developed a core outcome set for the treatment of NE. This will allow future trials to measure and report the same outcomes and ensure results can be compared. Future work should identify how best to measure the COS. IMPACT: We have identified seven outcomes that should be measured and reported in all studies for the treatment of neonatal encephalopathy. Previously, a core outcome set for neonatal encephalopathy treatments did not exist. This will help to reduce heterogeneity in outcomes reported in clinical trials and other studies, and help researchers identify the best treatments for neonatal encephalopathy.

Indexed as

Brain DiseasesInfant, Newborn, DiseasesDelphi TechniqueHumansInfant, NewbornOutcome Assessment, Health CareParentsQuality of LifeSystematic Reviews as TopicTreatment Outcome

Identifiers

PMID38135724
PMCPMC10920183
OpenAlexW4390105432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.